Component a of the collaborative influenza vaccine innovation centers (CIVICS) program to design and evaluate innovative influenza vaccine approaches, based on principles of influenza immunity, that…
Active Definitive Contract Awarded Last action
- Contract number
- 75N93019C00052
- Awardee
-
University Of Georgia Research Foundation, Inc. UEI NMJHD63STRC5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $76,786,980
Award facts
- Opportunity
-
- HHSNIHNIAIDBAA2018 Solicitation number
- Research Area 003 - Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases Award Notice · Posted Jun 1, 2018
- Contract value 65% obligated
-
- $76,786,980.25 Current, with exercised options
- $118,147,453.25 Potential, with all options
- Completion date 89% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Athens, GA 30602, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $2,218,092 | |
| Exercise an Option | $8,000,000 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $429,338 | |
| Other Administrative Action | $0 | |
| Change Order | $419,987 | |
| Exercise an Option | $8,000,000 | |
| Exercise an Option | $920,475 | |
| Exercise an Option | $9,062,958 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $491,168 | |
| Exercise an Option | $225,441 | |
| Exercise an Option | $949,281 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $11,203,427 | |
| Change Order | $326,145 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $3,600,000 | |
| Change Order | $787,877 | |
| Change Order | $1,463,580 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $8,000,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $222,831 | |
| Exercise an Option | $10,526,979 | |
| Change Order | $1,939,401 | |
| Change Order | $0 | |
| Original award | $8,000,000 |
Show all 31
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a definitive contract to University Of Georgia Research Foundation, Inc. for $118.147 million on September 10, 2019, to design and evaluate innovative influenza vaccine approaches under Component A of the Collaborative Influenza Vaccine Innovation Centers (CIVICS) program, structured as cost, no fee. The contract runs through September 9, 2027.
Performance is centered in Athens, Georgia. The originating solicitation calls for design and evaluation of innovative influenza vaccine approaches based on principles of influenza immunity to achieve durable, robust, and broadly protective immune responses, with particular focus on high-risk populations.
Under the Service Contract Inventory reporting framework, the contract delivered $10.2 million in FY2025 across 38.3 full-time equivalents and 79,604 contractor hours. The derived government-paid hourly rate in FY2025 was $128.64 per hour, part of a rising trend from $102.80/hr in FY2021. The contract engages a multi-vendor team, with 12 subcontractors performing 78 percent of contractor hours in FY2025.
Subcontractors include University Of North Carolina At Chapel Hill, University Of Rochester, Cleveland Clinic Lerner College Of Medicine Of Case Western Reserve University, Florida State University, Case Western Reserve University, St Jude Children's Research Hospital Inc., Mayo Clinic, Auburn University, University Of Montana, University Of California Santa Cruz, and The General Hospital Corporation, supporting research centers focused on influenza vaccine development for high-risk populations and collaborative vaccine innovation across academic and medical research institutions.
Description
Component a of the collaborative influenza vaccine innovation centers (CIVICS) program to design and evaluate innovative influenza vaccine approaches, based on principles of influenza immunity, that achieve durable, robust and broadly protective immu
Subawards
Show all 32
Quick answers
Who was awarded contract 75N93019C00052?
75N93019C00052 was awarded to University Of Georgia Research Foundation, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 10, 2019.
How much is contract 75N93019C00052 worth?
The government has obligated $76,786,980 on 75N93019C00052. Its potential value, with all options, is $118,147,453.
Was contract 75N93019C00052 competed?
The extent of competition for 75N93019C00052 was full and open competition. The government received 9 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award